Bill > AB378

This bill creates the Alternative Therapy Pilot Program, which aims to provide access to psychedelic-assisted treatment for specific mental health patients, primarily veterans and first responders. The program, to be administered by the Division of Public and Behavioral Health, will develop experimental pilot clinic programs using psychedelic substances like psilocybin, psilocin, dimethyltryptamine, ibogaine, and mescaline to treat mental health conditions such as post-traumatic stress disorder, depression, and anxiety. Eligible patients must be 21 or older and either honorably discharged from the military or previously employed as a first responder. The Division will be responsible for creating regulations to ensure patient safety, collecting comprehensive data on treatment outcomes, establishing an advisory committee, and authorizing at least one entity to produce these substances. The bill provides immunity from civil, criminal, and administrative liability for approved participants and producers, and requires the Division to submit annual reports to the Legislature. Importantly, the program emphasizes medical supervision, informed consent, and comprehensive patient care, with a focus on developing innovative mental health treatment approaches.

Budget and Finance, Health and Social Services

https://www.leg.state.nv.us/App/NELIS/REL/83rd2025/Bill/12520/Overview